Thomas P. Cirrito,Ivan Bergstein,Christopher Brooks
申请号：
US14386242
公开号：
US20150079135A1
申请日:
2013.03.19
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Provided herein are methods for treating cancer in a subject comprising administering to the subject a therapeutically effective amount of a peptide derived from the EphA2 protein and/or the IL-13Rα2 protein and monitoring the amount of cancer stem cells in said subject. Also provided herein are methods for monitoring the efficacy of an EphA2 peptide-based cancer treatment or an IL-13Rα2 peptide-based cancer treatment in a patient with cancer, comprising monitoring the amount of cancer stem cells in said subject prior to, during, and/or following cancer treatment of a patient.
